Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR-When and How?

Juan Hernando Del Portillo1, Julio Farjat-Pasos1, Attilio Galhardo1

  • 1Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

PubMed

Insights

For severe aortic stenosis and coronary artery disease, surgical aortic valve replacement with bypass grafting is best for complex cases. Transcatheter aortic valve replacement with intervention suits high-risk patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Increasing transcatheter aortic valve replacement (TAVR) candidates with severe aortic stenosis (AS) also have coronary artery disease (CAD).
  • Optimal revascularization strategies for concurrent AS and CAD require careful consideration due to potential impacts on outcomes.
  • Prevalence of concurrent AS and CAD varies based on definitions and study populations.

Purpose of the Study:

  • To define the appropriate revascularization strategy for patients with concomitant severe aortic stenosis and coronary artery disease.
  • To compare outcomes of different revascularization approaches in this patient group.
  • To identify factors influencing the choice between TAVR+PCI and SAVR+CABG.

Main Methods:

  • Review of existing literature comparing surgical aortic valve replacement with coronary artery bypass grafting (SAVR+CABG) versus transcatheter aortic valve replacement with percutaneous coronary intervention (TAVR+PCI).
  • Analysis of outcomes including mortality, stroke, and major cardiovascular events based on CAD complexity and surgical risk.
  • Consideration of factors like PCI timing, ejection fraction, and valve durability.

Main Results:

  • SAVR+CABG shows favorable long-term prognosis.
  • TAVR+PCI outcomes depend on CAD complexity and revascularization completeness.
  • No significant differences in mortality or stroke between SAVR+CABG and TAVR+PCI in low-intermediate risk/CAD patients.
  • SAVR+CABG may offer lower major cardiovascular events in complex CAD patients.

Conclusions:

  • SAVR+CABG is preferred for low-intermediate surgical risk patients with complex CAD.
  • TAVR+PCI is suitable for high surgical risk patients needing complete or reasonable incomplete revascularization.
  • Further research is needed on alternative CAD assessment methods for guiding revascularization in severe AS patients.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
9
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
23
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10